Max Planck Institute for Molecular Biomedicine
About
In recent decades, authors affiliated with Max Planck Institute for Molecular Biomedicine have published 1.0k papers, which have received a total of 59.7k indexed citations.
Scholars at this organization have produced 736 papers in Molecular Biology, 162 papers in Cell Biology and 131 papers in Immunology on the topics of Pluripotent Stem Cells Research (250 papers), CRISPR and Genetic Engineering (148 papers) and Angiogenesis and VEGF in Cancer (118 papers). Their work is cited by papers focused on Molecular Biology (37.9k citations), Immunology (7.6k citations) and Cell Biology (7.5k citations). Authors at Max Planck Institute for Molecular Biomedicine collaborate with scholars in Germany, United States and South Korea and have published in prestigious journals including Nature, Science and Cell. Some of Max Planck Institute for Molecular Biomedicine's most productive authors include Ralf H. Adams, Hans R. Schöler, Dietmar Vestweber, Alexander Zarbock and Marcos J. Araúzo‐Bravo.
In The Last Decade
Explore institutions with similar magnitude of impact
Top fields scholars at Istituto Nazionale per le Ricerche Cardiovascolari are working on Top journals impacted by scholars at Immune Regulation (United Kingdom) Top authors scholars at California Environmental Protection Agency are specifically Top countries impacted by scholars at Associazione Nazionale Medici Cardiologi Ospedalieri Top fields impacted by scholars at National Institute for Nanotechnology Top countries scholars at Turku Centre for Biotechnology are collaborate with authors working in Top fields impacted by scholars at Cancer Research UK Cambridge Center Top fields impacted by scholars at NOAA Oceanic and Atmospheric Research